Long-term safety of tiotropium/olodaterol Respimat® in patients with moderate-to-very severe COPD and renal impairment in the TONADO® studies

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, June 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

So far, Altmetric has seen 1 YouTube video.

Video abstract of original research paper “Long-term safety of tiotropium/olodaterol Respimat® in patients with moderate-to-very…